BTG’s varicose-vein drug successful in U.S. study
LONDON (Reuters) – British pharmaceutical firm BTG said the first of two U.S. trials of its varicose vein treatment Varisolve had met all its end-points, bringing a launch of the long-delayed product a step closer. Varisolve is a ground-breaking t…
View full post on Yahoo! Health News
BTG's, drug, Study, successful, U.S., varicosevein